These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9672848)

  • 1. Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.
    Janetzki S; Blachere NE; Srivastava PK
    J Immunother; 1998 Jul; 21(4):269-76. PubMed ID: 9672848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
    Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
    Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
    Udono H; Levey DL; Srivastava PK
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3077-81. PubMed ID: 7909157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
    Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
    J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
    Lu WW; Zhang H; Li YM; Ji F
    World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
    Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual nature of specific immunological activity of tumor-derived gp96 preparations.
    Chandawarkar RY; Wagh MS; Srivastava PK
    J Exp Med; 1999 May; 189(9):1437-42. PubMed ID: 10224283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1.
    Navaratnam M; Deshpande MS; Hariharan MJ; Zatechka DS; Srikumaran S
    Vaccine; 2001 Jan; 19(11-12):1425-34. PubMed ID: 11163665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70.
    Udono H; Yamano T; Kawabata Y; Ueda M; Yui K
    Int Immunol; 2001 Oct; 13(10):1233-42. PubMed ID: 11581168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
    Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
    J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
    Heike M; Weinmann A; Bethke K; Galle PR
    Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The killing effect of cytotoxic T lymphocytes on esophageal adenocarcinoma cells mediated by gp96-peptide complexes].
    Ma LP; Pan XY; Li N; Liu YJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):525-8. PubMed ID: 15489936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequence.
    Moré S; Breloer M; Fleischer B; von Bonin A
    Immunol Lett; 1999 Aug; 69(2):275-82. PubMed ID: 10482363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg suppress CTL responses upon immunization with HSP gp96.
    Liu Z; Li X; Qiu L; Zhang X; Chen L; Cao S; Wang F; Meng S
    Eur J Immunol; 2009 Nov; 39(11):3110-20. PubMed ID: 19839010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.